Erratum: Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: Efficiency of leukocyte depletion filters in the removal of tumor cells (Transplantation (2008) 85 (863-869) DOI: 10.1097/TP.0b013e3181671f2e);Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: Efficiency of leukocyte depletion filters in the removal of tumor cells

Transplantation

Volumn 85, Issue 6, 2008, Pages 863-869

  Liang, Ting Bo ^a   Li, Dong Lin ^a   Liang, Liang ^a   Li, Jun Jian ^a   Bai, Xue Li ^a   Yu, Wei ^a   Wang, Wei Lin ^a   Shen, Yan ^a   Zhang, Min ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Intraoperative blood salvage; Leukocyte depletion filter; Liver transplantation; Tumor cell

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOTRANSFUSION UNIT; BLOOD FILTRATION; BLOOD SALVAGE; BLOOD SAMPLING; CELL SEPARATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTAMINATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; TUMOR CELL;

EID: 41149110718     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000002823     Document Type: Erratum

References (27)

1. Ozier Y, Albi A. Liver transplant surgery and transfusion. Int Anesthesiol Clin 2004; 42: 147.
2. Hendriks HG, van der Meer J, Klompmaker IJ, et al. Blood loss in orthotopic liver transplantation: A retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11: S87.
3. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirement, and measures to reduce them. Liver Transplant 2003; 9: 1320.
4. Adias TC, Jeremiah Z, Uko E, et al. Autologous blood transfusion - a review. S Afr J Surg 2006; 44: 114.
5. Phillips SD, Maguire D, Deshpande R, et al. A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. Transplantation 2006; 81: 536.
6. Elias D, Lapierre V, Billard V. Perioperative autotransfusion with salvage blood in cancer surgery. Ann Fr Anesth Reanim 2000; 19: 739.
7. Oefelein MG, Kaul K, Herz B, et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 1996; 155: 238.
8. Kudo H, Fujita H, Hanada Y, et al. Cytological and bacteriological studies of intraoperative autologous blood in neurosurgery. Surg Neurol 2004; 62: 195.
9. Dale RF, Kipling RM, Smith MF, et al. Separation of malignant cells during autotransfusion. Br J Surg 1988; 75: 581.
10. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387.
11. Futamura N, Nakanishi H, Hirose H, et al. The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg 2005; 71: 585.
12. Fruhauf NR, Dumpich O, Kaudel CP, et al. Filtration of malignant cells: Tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Perfusion 2001; 16: S51.
13. Gwak MS, Lee KW, Kim SY, et al. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transpl 2005; 11: 331.
14. Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214.
15. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
16. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
17. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: Meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36: 175.
18. Hanazaki K, Kajikawa S, Shimozawa N, et al. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 2005; 52: 524.
19. Edelman MJ, Potter P, Mahaffey KG, et al. The potential for reintroduction of tumor cells during intraoperative blood salvage: Reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 1996; 47: 179.
20. Muller M, Kuhn DF, Hinrichs B, et al. Is the elimination of osteosarcoma cells with intraoperative "mesh autotransfusion" and leukocyte depletion filters possible? Anaesthesist 1996; 45: 834.
21. Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 1996; 40: 118.
22. Steneker I, van Luyn MJ, van Wachem PB, et al. Electronmicroscopic examination of white cell reduction by four white cell-reduction filters. Transfusion 1992; 32: 450.
23. Pietersz RN, van der Meer PF, Seghatchian MJ. Update on leucocyte depletion of blood components by filtration. Transfus Sci 1998; 19: 321.
24. Paterlini-Brechot P, Vona G, Brechot C. Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions. Semin Cancer Biol 2000; 10: 241.
25. Gross HJ, Verwer B, Houck D, et al. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc Natl Acad Sci USA 1995; 92: 537.
26. Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418.
27. Muscari F, Suc B, Vigouroux D, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: Does it increase the risk of neoplastic recurrence? Transpl Int 2005; 18: 1236.